In vitro effects of cyclooxygenase inhibitors in whole blood of horses, dogs, and cats

被引:174
作者
Brideau, C
Van Staden, C
Chan, CC
机构
[1] Merck Frosst Ctr Therapeut Res, Dept Biochem & Mol Biol, Kirkland, PQ H9R 4P8, Canada
[2] Merck Frosst Ctr Therapeut Res, Dept Pharmacol, Kirkland, PQ H9R 4P8, Canada
关键词
D O I
10.2460/ajvr.2001.62.1755
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
Objective-To determine potency and selectivity of nonsteroidal anti-inflammatory drugs (NSAID) and cyclcoxygenase- (COX-) specific inhibitors in whole blood from horses, dogs, and cats. Sample Population-Blood samples from 30 healthy horses, 48 healthy dogs, and 9 healthy cats. Procedure-Activities of COX-1 and COX-2 were determined by measuring coagulation-induced thromboxane B-2 and lipopolysaccharide-induced prostaglandin E-2 concentrations, respectively, in whole blood with and without the addition of various concentrations of phenylbutazone, flunixin meglumine, ketoprofen, diclofenac, indomethacin, meloxicam, carprofen, 5-bromo-2[4-fluorophenyl]-3-[4-methylsulfonylphenyl]-thiophene (DuP 697), 5,5-dimethyl-3-(3-fluorophenyl)-4-(4-methylsulphonyl) phenyl-2(5H)-furan one (DFU), 3-(3,4-difluorophenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone (MF-tricyclic), and celecoxib. Potency of each test compound was determined by calculating the concentration that resulted in inhibition of 50% of COX activity (IC50)Selectivity was determined by calculating the ratio of IC50 for COX-1 to IC50 for COX-2 (COX-1/COX-2 ratio). Results-The novel compound DFU was the most selective COX-2 inhibitor in equine, canine, and feline blood; COX-1/COX-2 ratios were 77.5, 74, and 69, respectively. Carprofen was the weakest inhibitor of COX-2, compared with the other COX-2 selective inhibitors, and did not inhibit COX-2 activity in equine blood, In contrast, NSAID such as phenylbutazone and flunixin meglumine were more potent inhibitors of COX-1 than COX-2 in canine and equine blood. Conclusions and Clinical Relevance-The novel COX-2 inhibitor DFU was more potent and selective in canine, equine, and feline blood, compared with phenylbutazone, flunixin meglumine, and carprofen. Compounds that specifically inhibit COX-2 may result in a lower incidence of adverse effects, compared with NSAID, when administered at therapeutic dosages to horses, dogs, and cats.
引用
收藏
页码:1755 / 1760
页数:6
相关论文
共 25 条
[1]   GASTROINTESTINAL DAMAGE ASSOCIATED WITH THE USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
ALLISON, MC ;
HOWATSON, AG ;
TORRANCE, CJ ;
LEE, FD ;
RUSSELL, RI .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (11) :749-754
[2]   Differential effect of a selective cyclooxygenase-2 inhibitor versus indomethacin on renal blood flow in conscious volume-depleted dogs [J].
Black, SC ;
Brideau, C ;
Cirino, M ;
Belley, M ;
Bosquet, J ;
Chan, CC ;
Rodger, IW .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1998, 32 (05) :686-694
[3]   A human whole blood assay for clinical evaluation of biochemical efficacy of cyclooxygenase inhibitors [J].
Brideau, C ;
Kargman, S ;
Liu, S ;
Dallob, AL ;
Ehrich, EW ;
Rodger, IW ;
Chan, CC .
INFLAMMATION RESEARCH, 1996, 45 (02) :68-74
[4]   Interpreting the clinical significance of the differential inhibition of cyclooxygenase-1 and cyclooxygenase-2 [J].
Brooks, P ;
Emery, P ;
Evans, JF ;
Fenner, H ;
Hawkey, CJ ;
Patrono, C ;
Smolen, J ;
Breeveld, F ;
Day, R ;
Dougados, M ;
Ehrich, EW ;
Gijon-Baños, J ;
Kvien, TK ;
Van Rijswijk, MH ;
Warner, T ;
Zeidler, H .
RHEUMATOLOGY, 1999, 38 (08) :779-788
[5]  
Chan CC, 1999, J PHARMACOL EXP THER, V290, P551
[6]   RENAL ABNORMALITIES AND AN ALTERED INFLAMMATORY RESPONSE IN MICE LACKING CYCLOOXYGENASE-II [J].
DINCHUK, JE ;
CAR, BD ;
FOCHT, RJ ;
JOHNSTON, JJ ;
JAFFEE, BD ;
COVINGTON, MB ;
CONTEL, NR ;
ENG, VM ;
COLLINS, RJ ;
CZERNIAK, PM ;
GORRY, SA ;
TRZASKOS, JM .
NATURE, 1995, 378 (6555) :406-409
[7]  
Ehrich EW, 1999, J RHEUMATOL, V26, P2438
[8]   HUMAN PLATELET ERYTHROLEUKEMIA CELL PROSTAGLANDIN G/H SYNTHASE - CDNA CLONING, EXPRESSION, AND GENE CHROMOSOMAL ASSIGNMENT [J].
FUNK, CD ;
FUNK, LB ;
KENNEDY, ME ;
PONG, AS ;
FITZGERALD, GA .
FASEB JOURNAL, 1991, 5 (09) :2304-2312
[9]  
GANS KR, 1990, J PHARMACOL EXP THER, V254, P180
[10]   INHIBITION OF CONSTITUTIVE AND INDUCIBLE CYCLOOXYGENASE ACTIVITY IN HUMAN PLATELETS AND MONONUCLEAR-CELLS BY NSAIDS AND COX-2 INHIBITORS [J].
GROSSMAN, CJ ;
WISEMAN, J ;
LUCAS, FS ;
TREVETHICK, MA ;
BIRCH, PJ .
INFLAMMATION RESEARCH, 1995, 44 (06) :253-257